Oncology Nursing News: Top Stories of March 2020

Article

Here are the top 5 Oncology Nursing News® stories for March 2020.

Here are the top 5 Oncology Nursing News® stories for March 2020.

5. Navigation Helps At-Risk Patients Catch Breast Cancer Earlier

While national guidelines recommend that women at an increased risk of breast cancer undergo additional screening and get extra services, many individuals do not adhere to these recommendations simply because they are unaware of their risk. In this piece, we looked at how a lay navigator can help remedy this problem.

4. Expert Addresses Coronavirus and Cancer Innovation

The novel coronavirus (COVID-19) spreading across the world represents a distinct challenge for all physicians, especially oncologists who commonly treat patients who have compromised immune systems. The spread of the virus was discussed by Scott Gottlieb, MD, during the keynote address at the 37th Annual Miami Breast Cancer Conference®, which we covered in this story.

3. FDA Green Lights Phase III Tocilizumab Trial for COVID-19 Pneumonia

The FDA has approved the examination of oncology supportive care drug tocilizumab (Actemra) for use in combination with standard of care for the treatment of hospitalized adult patients with severe COVID-19 pneumonia. Learn more in this news brief.

2. Nurses, Get to Know Your Patients. It Means More Than You Think

Oncology nurses made it a point to get to know Barbara Bigelow, a breast cancer survivor, while she was getting treatment. In this video, she explains why that made a big difference.

1. NCCN Offers Guidance for Cancer Centers Amid COVID-19 Pandemic

After hearing insight from one of their member institutions, the National Comprehensive Cancer Network shares advice for healthcare providers on the novel COVID-19 pandemic.

Thanks for reading!

Recent Videos
Ann H. Partridge, MD, MPH, in an interview with Oncology Nursing News at 2024 ESMO Congress.
Pattie Jakel
Christine Wylie
Daly
Grace Choong
Ahulwalia on Targeting the Blood Brain Barrier With Novel Immunotherapies and Precision Oncology
Expert in oncology
© 2024 MJH Life Sciences

All rights reserved.